Search Tag: sleep apnoea

IMAGING Management

2021 11 Apr

A recent study has shown that women with breast or endometrial cancer have increased levels of obstructive sleep apnoea (OSA). Researchers from the Ludwig Engel Centre for Respiratory Research, the Westmead Institute for Medical Research, and the University of Sydney, Australia, found that various epidemiological studies reported increased mortality...Read more

IMAGING Management

2019 26 Jun

Research presented at the Society of Nuclear Medicine and Molecular Imaging's 2019 Annual Meeting draws a strong link between severe obstructive sleep apnea (OSA) and impaired coronary flow reserve, which is an early sign of the heart disease atherosclerosis. Using 13N-ammonia positron emission tomography/computed tomography (PET/CT), researchers...Read more

Cardiology Management

2019 01 May

A new study has shed light on the link between higher body mass index (BMI) and serious health outcomes and death in over 2.8 million adults representative of the UK population. The new estimates, being presented at this year's European Congress on Obesity (ECO) in Glasgow, UK (28 April-1 May), indicate that adults with severe obesity class...Read more

Cardiology Management

2016 27 Sep

A new statement from the American Heart Association (AHA) says that sleep duration and sleep disorders may be risk factors for cardiometabolic and cardiovascular disease. This is based on a literature review of studies the results of which are published in Circulation . Dr Marie-Pierre St-Onge (Institute of Human Nutrition, Columbia University,...Read more

Cardiology Management

2016 17 May

Myocardial fibrosis could be a future therapeutic target after researchers found it correlated with adverse cardiovascular outcomes in patients with obstructive sleep apnoea (OSA) referred for cardiac magnetic resonance (CMR). The study was presented today at EuroCMR 2016 by Dr Yaron Fridman, a cardiology fellow at the Heart and Vascular Institute,...Read more

ICU Management

2015 23 May

Study Did Not Meet Primary Endpoint Safety Signal of Increased Cardiovascular Mortality Found for ASV Therapy in People with Predominant Central Sleep Apnoea and Symptomatic Chronic Heart Failure Results and Safety Signal Observed Only in This Specific Study Population ResMed (NYSE: RMD) has announced that SERVE-HF, a multinational, multicentre,...Read more